Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$12,154,749
+$781,690 QoQ
Shares Held
47,859
+2.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#994
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NICOLET BANKSHARES INC holds $53,996,275 across 11 Drug Manufacturers - General names. JNJ ranks #2 (22.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,329 | $15,987,203 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
47,859 | $12,154,749 | |
| 3 | ABBV |
AbbVie Inc.
|
42,391 | $10,667,269 | |
| 4 | MRK |
Merck & Co., Inc.
|
28,130 | $3,614,705 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
50,571 | $2,913,900 | |
| 6 | PFE |
Pfizer Inc
|
109,634 | $2,639,986 | |
| 7 | GSK |
GSK plc
|
44,504 | $2,332,898 | |
| 8 | BIIB |
Biogen Inc.
|
6,476 | $1,399,203 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,154,749 | 47,859 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $11,373,059 | 46,527 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $2,335,016 | 11,283 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,124,542 | 11,458 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,602,500 | 10,491 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,474,151 | 8,889 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,233,608 | 8,530 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,370,379 | 8,456 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,295,854 | 8,866 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,366,128 | 8,636 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,373,669 | 8,764 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,346,770 | 8,647 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,457,072 | 8,803 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,139,620 | 13,804 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,449,958 | 13,869 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,377,704 | 14,555 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,646,851 | 14,911 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $2,626,725 | 14,821 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,206,460 | 12,898 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,050,404 | 12,696 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,980,833 | 12,024 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,878,027 | 11,427 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $1,645,565 | 10,456 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,581,998 | 10,626 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,463,677 | 10,408 | Shares | Defined | 2020-07-22 | |
| 2020-03-31 | $1,487,276 | 11,342 | Shares | Defined | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||